Skip to main content
Woman receiving flu vaccine - Precision Clinical Research

Help advance influenza research

Overview

Could you be part of the next vaccine breakthrough?
Want to help your community by advancing influenza research and potentially be compensated? See if you are eligible to join a clinical study. Vaccination is the primary method for preventing influenza and its potentially severe complications. Efficacy of the conventional influenza vaccines in the adult population is demonstrated to be high.

Ages

50 and above

Study Topics

Vaccine

First Name*
Last Name*
Email*
Phone*
ZIP Code*
Best time to call
Date of Birth* (type or select date)
Sex*
Race*
How did you hear about us?
Questions/Comments

More Information About Flu and Influenza

It is estimated that the global disease burden from influenza includes up to a billion infections, 3–5 million cases of severe disease, and 290,000–650,000 deaths annually.Adults 65 years of age or older are particularly vulnerable to the complications resulting from influenza infections with higher rates of influenza‐associated complications and hospitalizations than younger people.Older adults make up the majority of influenza-related deaths, with up to 90% of deaths occurring in this age group.

Qualified participants of this research study will receive at no cost

  • Study-related physical exams
  • Study-related lab work
  • Study-related procedures

Compensation for time and travel is available for qualified participants.

This research study is enrolling people who:

Are you 50 years or older?

Are generally healthy or have stable chronic conditions

Are not pregnant

Have not had a COVID-19 or any other vaccine in the last month

Do You Not Meet the Criteria for This Study?

You could still participate in other studies. Contact us to be added to our database and you’ll be notified about our future studies that may be right for you.